到 2027 年北美起搏器市场 - 按产品类型(植入式起搏器、体外起搏器)、按技术(单腔、双腔和双心室)、最终用户(医院、门诊手术中心等)进行区域分析和预测,和国家

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027


No. of Pages: 137    |    Report Code: TIPRE00005754    |    Category: Life Sciences

North America Pacemakers Market

北美起搏器市场预计将从 2018 年的 26.071 亿美元增至 2027 年的 51.442 亿美元。预计 2019-2027 年该市场的复合年增长率为 8.0%。

 

推动市场增长的关键因素正在上升心血管疾病的发病率、该地区存在大量易患慢性心脏病风险的老年人口、市场中主要参与者的存在以及北美参与者在市场上取得的重大技术进步。

 

心血管疾病是一类与血管和心脏相关的多种疾病。根据世界卫生组织 2017 年的数据,大约 90% 的心血管疾病是可以预防的。世界卫生组织还指出,CVD 是美国和全世界死亡的主要原因。 2017年,根据世界卫生组织的数据,心血管疾病的患病率不断上升,是全世界死亡的主要原因。据世界卫生组织称,心血管疾病是发病和死亡的主要原因之一,占全球死亡率的 30%。此外,根据美国疾病控制与预防中心的数据,冠心病 (CHD) 是最常见的心脏病类型,每年导致超过 37 万人死亡。此外,根据美国心脏协会的数据,2016年,冠心病是美国心血管疾病死亡的主要原因(43.2%),其次是中风(16.9%)、高血压(9.8%)、心脏病衰竭(9.3%)、动脉疾病(3.0%)和其他心血管疾病(17.7%)。因此,全球心血管疾病的高患病率预计将引领未来几年的市场增长。

 

起搏器市场根据产品类型细分为植入式起搏器和体外起搏器。 2018年,按产品类型划分,植入式起搏器细分市场占据最大市场份额。此外,从 2019 年到 2027 年,同一领域的起搏器市场的需求预计也将以 8.3% 的最快复合年增长率增长。这些设备的普及主要依赖于报销的可用性,从而减轻人们的经济负担发达经济体中心血管疾病患病率较高的患者。此外,植入式起搏器的市场渗透率较高,因其风险低等优势而成为首选。

北美起搏器——市场细分

按产品类型

  • 植入式起搏器
  • 体外起搏器
  • 按技术

    • 单腔
    • 双腔
    • 双心室
    • < /ul>

      作者

      最终用户

      • 医院
      • 流动手术中心
      • 其他

      按国家/地区

      • 美国
      • 加拿大
      • 墨西哥< /li>

       

      提及的公司

      • Medico SpA
      • Vitatron
      • 雅培
      • 美敦力
      • OSCOR
      • LivaNova Plc
      • Abiomed
      • 波士顿科学公司
      • Biotronik
      • 乐普医疗


      North America Pacemakers Strategic Insights

      Strategic insights for North America Pacemakers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

      strategic-framework/north-america-pacemakers-market-strategic-framework.webp
      Get more information on this report

      North America Pacemakers Report Scope

      Report Attribute Details
      Market size in 2018 US$ 2,607.1 Million
      Market Size by 2027 US$ 5,144.2 Million
      Global CAGR (2019 - 2027) 8.0%
      Historical Data 2016-2017
      Forecast period 2019-2027
      Segments Covered By 产品类型
      • 植入式起搏器
      • 体外起搏器
      By 技术
      • 单腔
      • 双腔
      • 双心室
      By 最终用户
      • 医院
      • 门诊手术中心
      Regions and Countries Covered 北美
      • 美国
      • 加拿大
      • 墨西哥
      Market leaders and key company profiles
    • Medico S.p.A.
    • Vitatron
    • Abbott
    • Medtronic
    • OSCOR
    • LivaNova Plc
    • Abiomed
    • Boston Scientific Corporation
    • Biotronik
    • Lepu Medical
    • Get more information on this report

      North America Pacemakers Regional Insights

      The regional scope of North America Pacemakers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

      geography/north-america-pacemakers-market-geography.webp
      Get more information on this report

The List of Companies - North America Pacemakers Market

The List of Companies

 

  1. Medico S.p.A.
  2. Vitatron
  3. Abbott
  4. Medtronic
  5. OSCOR
  6. LivaNova Plc
  7. Abiomed
  8. Boston Scientific Corporation
  9. Biotronik
  10. Lepu Medical

 

Frequently Asked Questions
How big is the North America Pacemakers Market?

The North America Pacemakers Market is valued at US$ 2,607.1 Million in 2018, it is projected to reach US$ 5,144.2 Million by 2027.

What is the CAGR for North America Pacemakers Market by (2019 - 2027)?

As per our report North America Pacemakers Market, the market size is valued at US$ 2,607.1 Million in 2018, projecting it to reach US$ 5,144.2 Million by 2027. This translates to a CAGR of approximately 8.0% during the forecast period.

What segments are covered in this report?

The North America Pacemakers Market report typically cover these key segments-

  • 产品类型 (植入式起搏器, 体外起搏器)
  • 技术 (单腔, 双腔, 双心室)
  • 最终用户 (医院, 门诊手术中心)
  • What is the historic period, base year, and forecast period taken for North America Pacemakers Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Pacemakers Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in North America Pacemakers Market?

    The North America Pacemakers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Medico S.p.A.
  • Vitatron
  • Abbott
  • Medtronic
  • OSCOR
  • LivaNova Plc
  • Abiomed
  • Boston Scientific Corporation
  • Biotronik
  • Lepu Medical
  • Who should buy this report?

    The North America Pacemakers Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Pacemakers Market value chain can benefit from the information contained in a comprehensive market report.